Former SpaceX Engineers Helping Scientists Find Cures For Genetic Diseases Using Crispr

genetic engineering crispr

Biology is undergoing a substantial shift, as scientists now have a brand-new tool to modify our genetic code.

Advances in a technology called CRISPR — which stands for “Clustered Regularly Interspaced Short Palindromic Repeats” — offer researchers something like a set of “scissors,” so they can snip away at genetic material with the objective of treating disease, growing new crops and more.

  • Synthego’s founders are ex-SpaceX, the private space company established by Elon Musk.
  • They state CRISPR is a biological breakthrough that will assist scientists discover treatments for common hereditary diseases.
  • Synthego wishes to assist researchers use tools like CRISPR to edit the genetic code.

2 former SpaceX engineers, Michael and Paul Dabrowski, saw a chance that cannot be missed. Neither sibling has a background in genes, however they saw a chance to utilize software to assist researchers automate their research.

” As a field, CRISPR and genome engineering is extremely at an early stage, “Synthego’s Paul Dabrowski informed us.

” This, as a computer engineer, resembles being, say, in the 1970’s with computers, where everybody had mainframes and there were very few computer users.”

READ MORE ABOUT CRISPR HERE: WHAT IS CRISPR?

LiveScience.Tech and CNBC sat down with the Dabrowskis to talk about how their start-up, called Synthego, makes it much easier for researchers to utilize tools like CRISPR to discover treatments for diseases in the next decade. Here’s what they had to state.

Recommended For You

About the Author: livescience

Leave a Reply

Your email address will not be published. Required fields are marked *